AIkido Pharma Profit Margin

AIkido Pharma (AIKI) currently reports a profit margin of -51.93% as of June 2026. That compares with -29.83% in the prior-year period — down 74.1% year over year. That is below the Industrials sector average of 8.31%. Use the charts on this page to explore AIkido Pharma's profit margin history and peer comparisons.

AIkido Pharma's profit margin decreased from -29.83% to -51.93% — a 74.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AIkido Pharma's profit margin of -51.93% is lower than the Industrials sector average of 8.31%. That is roughly 724.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but AIkido Pharma's current -51.93% should be judged against Industrials norms (sector average: 8.31%) and against AIKI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -51.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 8.31%. From there, open related valuation or income-statement pages for AIkido Pharma, and consider following AIKI for alerts when major investors trade the stock.